Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis
- PMID: 26286821
- PMCID: PMC4717368
- DOI: 10.1136/bjophthalmol-2015-307223
Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis
Abstract
Systematic review of published population based surveys to examine the relationship between primary open angle glaucoma (POAG) prevalence and demographic factors. A literature search identified population-based studies with quantitative estimates of POAG prevalence (to October 2014). Multilevel binomial logistic regression of log-odds of POAG was used to examine the effect of age and gender among populations of different geographical and ethnic origins, adjusting for study design factors. Eighty-one studies were included (37 countries, 216 214 participants, 5266 POAG cases). Black populations showed highest POAG prevalence, with 5.2% (95% credible interval (CrI) 3.7%, 7.2%) at 60 years, rising to 12.2% (95% CrI 8.9% to 16.6%) at 80 years. Increase in POAG prevalence per decade of age was greatest among Hispanics (2.31, 95% CrI 2.12, 2.52) and White populations (1.99, 95% CrI 1.86, 2.12), and lowest in East and South Asians (1.48, 95% CrI 1.39, 1.57; 1.56, 95% CrI 1.31, 1.88, respectively). Men were more likely to have POAG than women (1.30, 95% CrI 1.22, 1.41). Older studies had lower POAG prevalence, which was related to the inclusion of intraocular pressure in the glaucoma definition. Studies with visual field data on all participants had a higher POAG prevalence than those with visual field data on a subset. Globally 57.5 million people (95% CI 46.4 to 73.1 million) were affected by POAG in 2015, rising to 65.5 million (95% CrI 52.8, 83.2 million) by 2020. This systematic review provides the most precise estimates of POAG prevalence and shows omitting routine visual field assessment in population surveys may have affected case ascertainment. Our findings will be useful to future studies and healthcare planning.
Keywords: Epidemiology; Glaucoma; Intraocular pressure; Public health.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Figures


Similar articles
-
Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.Ophthalmology. 2014 Nov;121(11):2081-90. doi: 10.1016/j.ophtha.2014.05.013. Epub 2014 Jun 26. Ophthalmology. 2014. PMID: 24974815
-
National and subnational prevalence and burden of glaucoma in China: A systematic analysis.J Glob Health. 2017 Dec;7(2):020705. doi: 10.7189/jogh.07.020705. J Glob Health. 2017. PMID: 29302324 Free PMC article.
-
Global variations and time trends in the prevalence of childhood myopia, a systematic review and quantitative meta-analysis: implications for aetiology and early prevention.Br J Ophthalmol. 2016 Jul;100(7):882-890. doi: 10.1136/bjophthalmol-2015-307724. Epub 2016 Jan 22. Br J Ophthalmol. 2016. PMID: 26802174 Free PMC article.
-
Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension.Cochrane Database Syst Rev. 2022 Jun 10;6(6):CD013817. doi: 10.1002/14651858.CD013817.pub2. Cochrane Database Syst Rev. 2022. PMID: 35686679 Free PMC article.
-
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1. MMWR Surveill Summ. 2025. PMID: 40493548 Free PMC article.
Cited by
-
Is primary trabeculectomy cost-effective for patients with advanced primary open angle glaucoma? Results from the Treatment of Advanced Glaucoma Study economic model.Br J Ophthalmol. 2024 Aug 22;108(9):1210-1215. doi: 10.1136/bjo-2023-323390. Br J Ophthalmol. 2024. PMID: 38336459 Free PMC article.
-
Determining Possible Shared Genetic Architecture Between Myopia and Primary Open-Angle Glaucoma.Invest Ophthalmol Vis Sci. 2019 Jul 1;60(8):3142-3149. doi: 10.1167/iovs.18-26231. Invest Ophthalmol Vis Sci. 2019. PMID: 31323684 Free PMC article.
-
SB772077B, A New Rho Kinase Inhibitor Enhances Aqueous Humour Outflow Facility in Human Eyes.Sci Rep. 2018 Oct 19;8(1):15472. doi: 10.1038/s41598-018-33932-8. Sci Rep. 2018. PMID: 30341380 Free PMC article.
-
From the PnTx2-6 Toxin to the PnPP-19 Engineered Peptide: Therapeutic Potential in Erectile Dysfunction, Nociception, and Glaucoma.Front Mol Biosci. 2022 Apr 11;9:831823. doi: 10.3389/fmolb.2022.831823. eCollection 2022. Front Mol Biosci. 2022. PMID: 35480885 Free PMC article. Review.
-
Analysis of pattern electroretinogram signals of early primary open-angle glaucoma in discrete wavelet transform coefficients domain.Int Ophthalmol. 2019 Oct;39(10):2373-2383. doi: 10.1007/s10792-019-01077-w. Epub 2019 Feb 6. Int Ophthalmol. 2019. PMID: 30725244
References
-
- World Health Organization. Visual impairment and blindness: Fact Sheet No 282 2014. (accessed Sep 2014).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical